Development and validation of the Uniform Data Set (v3.0) executive function composite score (UDS3-EF).


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
04 2021
Historique:
revised: 28 08 2020
received: 13 04 2020
accepted: 29 09 2020
pubmed: 21 11 2020
medline: 4 11 2021
entrez: 20 11 2020
Statut: ppublish

Résumé

Cognitive composite scores offer a means of precisely measuring executive functioning (EF). We developed the Uniform Data Set v3.0 EF composite score (UDS3-EF) in 3507 controls from the National Alzheimer's Coordinating Center dataset using item-response theory and applied nonlinear and linear demographic adjustments. The UDS3-EF was validated with other neuropsychological tests and brain magnetic resonance imaging from independent research cohorts using linear models. Final model fit was good-to-excellent: comparative fit index = 0.99; root mean squared error of approximation = 0.057. UDS3-EF scores differed across validation cohorts (controls > mild cognitive impairment > Alzheimer's disease-dementia ≈ behavioral variant frontotemporal dementia; P < 0.001). The UDS3-EF correlated most strongly with other EF tests (βs = 0.50 to 0.85, Ps < 0.001) and more with frontal, parietal, and temporal lobe gray matter volumes (βs = 0.18 to 0.33, Ps ≤ 0.004) than occipital gray matter (β = 0.12, P = 0.04). The total sample needed to detect a 40% reduction in UDS3-EF change (n = 286) was ≈40% of the next best measure (F-words; n = 714). The UDS3-EF is well suited to quantify EF in research and clinical trials and offers psychometric and practical advantages over its component tests.

Identifiants

pubmed: 33215852
doi: 10.1002/alz.12214
pmc: PMC8044003
mid: NIHMS1656307
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

574-583

Subventions

Organisme : NIA NIH HHS
ID : P50 AG047266
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG025688
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005133
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG047366
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG028383
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG013854
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG053760
Pays : United States
Organisme : NIA NIH HHS
ID : L30 AG057123
Pays : United States
Organisme : NIA NIH HHS
ID : K23 AG061253
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062428
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010124
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG023501
Pays : United States
Organisme : NIA NIH HHS
ID : K24 AG045333
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005142
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB022055
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010133
Pays : United States
Organisme : NIA NIH HHS
ID : U24 AG021886
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005146
Pays : United States
Organisme : NIA NIH HHS
ID : U24 AG072122
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062421
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG048234
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG035982
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG008702
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG063911
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG016976
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG008051
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005681
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG013846
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG047270
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062429
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005136
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG049638
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG012300
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062422
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG016573
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG019724
Pays : United States
Organisme : NIA NIH HHS
ID : K23 AG058752
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG008017
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010161
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG032306
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005138
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG032289
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062715
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG045390
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010129
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG019610
Pays : United States
Organisme : NINDS NIH HHS
ID : U54 NS092089
Pays : United States
Organisme : NINDS NIH HHS
ID : UH3 NS100608
Pays : United States

Informations de copyright

© 2020 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Références

J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Neuropsychologia. 2016 May;85:100-9
pubmed: 26948072
J Int Neuropsychol Soc. 2020 Jul;26(6):576-586
pubmed: 32063246
Alzheimers Dement. 2021 Apr;17(4):574-583
pubmed: 33215852
J Int Neuropsychol Soc. 2020 May;26(5):464-479
pubmed: 31822312
Appl Neuropsychol. 2002;9(3):187-91
pubmed: 12584085
Perspect Clin Res. 2010 Apr;1(2):67-9
pubmed: 21829786
Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):91-101
pubmed: 19474567
Cogn Affect Behav Neurosci. 2012 Jun;12(2):241-68
pubmed: 22282036
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
Eur Radiol. 2018 Jan;28(1):340-347
pubmed: 28695358
Neuropsychology. 2005 Jul;19(4):532-545
pubmed: 16060828
Arch Neurol. 2004 Apr;61(4):556-60
pubmed: 15096405
Brain Imaging Behav. 2012 Dec;6(4):502-16
pubmed: 22782295
Psychol Aging. 2010 Sep;25(3):606-19
pubmed: 20677882
Alzheimers Dement. 2020 Jan;16(1):11-21
pubmed: 31914230
J Clin Exp Neuropsychol. 2011 Apr;33(4):456-70
pubmed: 21271425
Cogn Psychol. 2000 Aug;41(1):49-100
pubmed: 10945922
J Int Neuropsychol Soc. 2008 Sep;14(5):746-59
pubmed: 18764970
Brain. 2017 Nov 1;140(11):3012-3022
pubmed: 29053778
Brain Imaging Behav. 2012 Dec;6(4):517-27
pubmed: 22644789
Cogn Behav Neurol. 2003 Dec;16(4):211-8
pubmed: 14665820
Neuropsychol Rev. 2006 Mar;16(1):17-42
pubmed: 16794878
Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):10-17
pubmed: 29240561
Alzheimers Dement (Amst). 2019 Dec 05;11:797-808
pubmed: 31872042
J Alzheimers Dis. 2015;44(2):585-98
pubmed: 25318544
Continuum (Minneap Minn). 2015 Jun;21(3 Behavioral Neurology and Neuropsychiatry):646-59
pubmed: 26039846
J Am Geriatr Soc. 2018 Jan;66(1):150-156
pubmed: 29355911
Alzheimers Dement (Amst). 2015 Dec 19;2:12-8
pubmed: 27239531
Clin Neuropsychol. 2015;29(1):67-81
pubmed: 25664575
Hum Brain Mapp. 2016 Aug;37(8):2959-75
pubmed: 27167614
J Int Neuropsychol Soc. 2014 Jan;20(1):11-9
pubmed: 24103232
Geroscience. 2020 Apr;42(2):445-465
pubmed: 32002785
Cerebellum. 2014 Feb;13(1):151-77
pubmed: 23996631

Auteurs

Adam M Staffaroni (AM)

Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California at San Francisco (UCSF), San Francisco, California, USA.

Breton M Asken (BM)

Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California at San Francisco (UCSF), San Francisco, California, USA.

Kaitlin B Casaletto (KB)

Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California at San Francisco (UCSF), San Francisco, California, USA.

Corrina Fonseca (C)

Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California at San Francisco (UCSF), San Francisco, California, USA.

Michelle You (M)

Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California at San Francisco (UCSF), San Francisco, California, USA.

Howard J Rosen (HJ)

Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California at San Francisco (UCSF), San Francisco, California, USA.

Adam L Boxer (AL)

Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California at San Francisco (UCSF), San Francisco, California, USA.

Fanny M Elahi (FM)

Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California at San Francisco (UCSF), San Francisco, California, USA.

John Kornak (J)

Department of Epidemiology and Biostatistics, Memory and Aging Center, University of California at San Francisco (UCSF), San Francisco, California, USA.

Dan Mungas (D)

Department of Neurology, University of California, Davis, Davis, California, USA.

Joel H Kramer (JH)

Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California at San Francisco (UCSF), San Francisco, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH